Share：
Share this content in WeChat
X
[Chinese][PDF]108284
• Review •
The application of cardiovascular magnetic resonance in risk stratification and prognosis evaluation in dilated cardiomyopathy
ZHANG Tianyue  FENG Yuling  WU Xingqiang  ZHAI Zhaohua  LI Rui 

Cite this article as: Zhang TY, Feng YL, Wu XQ, et al. The application of cardiovascular magnetic resonance in risk stratification and prognosis evaluation in dilated cardiomyopathy[J]. Chin J Magn Reson Imaging, 2021, 12(3): 95-97, 101. DOI:10.12015/issn.1674-8034.2021.03.023.


[Abstract] Dilated cardiomyopathy (DCM) represents a heterogeneous heart disease characterized by left ventricular dilatation and left ventricular systolic dysfunction, which could eventually result in heart failure, arrhythmia and sudden death and was also the main cause of heart transplantation. It is essential to accurately evaluate the degree of cardiac involvement, stratify disease risk, and identify high-risk individual who require close follow-up and intensive treatment in DCM patients. Cardiovascular magnetic resonance (CMR) is characterized by multi-modal and multi-parameter imaging. Using CMR cine sequences could accurately assess the morphological and functional abnormalities, whereas CMR-based histology and microstructure imaging could also provide more valuable prognosis information for DCM patients. This article will provide the overview of application progress of CMR in the risk stratification and prognosis assessment in DCM patients.
[Keywords] dilated cardiomyopathy；cardiovascular magnetic resonance；magnetic resonance imaging；prognosis；risk stratification

ZHANG Tianyue   FENG Yuling   WU Xingqiang   ZHAI Zhaohua   LI Rui*  

Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637007, China

Li R, E-mail: ddtwg_nsmc＠163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This article is supported by the National Natural Science Found of China No. 81801674 Nanchong-University Cooperative Research Project No. 19SXHZ0114
Received  2021-01-04
Accepted  2021-01-21
DOI: 10.12015/issn.1674-8034.2021.03.023
Cite this article as: Zhang TY, Feng YL, Wu XQ, et al. The application of cardiovascular magnetic resonance in risk stratification and prognosis evaluation in dilated cardiomyopathy[J]. Chin J Magn Reson Imaging, 2021, 12(3): 95-97, 101. DOI:10.12015/issn.1674-8034.2021.03.023.

1
Chinese Society of Cardiology, Chinese myocarditis cardiomyopathy Cooperative group. Chinese guidelines for the diagnosis and treatment of dilated cardiomyopathy. Chin J Clin Cardiol, 2018, 34(5): 421-434. DOI: 10.13201/j.issn.1001-1439.2018.05.001
2
Mitropoulou P, Georgiopoulos G, Figliozzi S, et al. Multi-modality imaging in dilated cardiomyopathy: with a focus on the role of cardiac magnetic resonance. Front Cardiovasc Med, 2020, 7: 97. DOI: 10.3389/fcvm.2020.00097
3
Francone M. Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance. ISRN Radiol, 2014, 2014: 365404. DOI: 10.1155/2014/365404
4
Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J, 2005, 26(15): 1461-1474. DOI: 10.1093/eurheartj/ehi258
5
Hashimura H, Kimura F, Ishibashi-Ueda H, et al. Radiologic-pathologic correlation of primary and secondary cardiomyopathies: mr imaging and histopathologic findings in hearts from autopsy and transplantation. Radiographics, 2017, 37(3): 719-736. DOI: 10.1148/rg.2017160082
6
Gupta A, Sharma P, Bahl A. Left ventricular size as a predictor of outcome in patients of non-ischemic dilated cardiomyopathy with severe left ventricular systolic dysfunction. Int J Cardiol, 2016, 221: 310-313. DOI: 10.1016/j.ijcard.2016.07.090
7
Gulati A, Ismail TF, Jabbour A, et al. Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail, 2013, 15(6): 660-70. DOI: 10.1093/eurjhf/hft019
8
Arenja N, Riffel JH, Fritz T, et al. Diagnostic and prognostic value of long-axis strain and myocardial contraction fraction using standard cardiovascular mr imaging in patients with nonischemic dilated cardiomyopathies. Radiology, 2017, 283(3): 681-691. DOI: 10.1148/radiol.2016161184
9
Karatolios K, Holzendorf V, Richter A, et al. Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol, 2016, 220: 608-612. DOI: 10.1016/j.ijcard.2016.06.167
10
Gulati A, Ismail TF, Jabbour A, et al. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation, 2013, 128(15): 1623-1633. DOI: 10.1161/CIRCULATIONAHA.113.002518
11
La Vecchia L, Zanolla L, Varotto L, et al. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. Am Heart J, 2001, 142(1): 181-189. DOI: 10.1067/mhj.2001.116071
12
Slavich M, Florian A, Bogaert J. The emerging role of magnetic resonance imaging and multidetector computed tomography in the diagnosis of dilated cardiomyopathy. Insights Imaging, 2011, 2(4): 453-469. DOI: 10.1007/s13244-011-0101-8
13
Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart, 2011, 97(20): 1675-1680. DOI: 10.1136/hrt.2011.225789
14
McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation, 2003, 108(1): 54-59. DOI: 10.1161/01.CIR.0000078641.19365.4C
15
Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA, 2013, 309(9): 896-908. DOI: 10.1001/jama.2013.1363
16
Alba AC, Gaztañaga J, Foroutan F, et al. Prognostic value of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy: an international, multi-institutional study of the MINICOR group. Circ Cardiovasc Imaging, 2020, 13(4): e010105. DOI: 10.1161/CIRCIMAGING.119.010105
17
Pi SH, Kim SM, Choi JO, et al. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction. J Cardiovasc Magn Reson, 2018, 20(1): 36. DOI: 10.1186/s12968-018-0466-7
18
Di Marco A, Anguera I, Schmitt M, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and Meta-analysis. JACC Heart Fail, 2017, 5(1): 28-38. DOI: 10.1016/j.jchf.2016.09.017
19
Halliday BP, Baksi AJ, Gulati A, et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC Cardiovasc Imaging, 2019, 12(8Pt 2): 1645-1655. DOI: 10.1016/j.jcmg.2018.07.015
20
Leyva F, Taylor RJ, Foley PW, et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol, 2012, 60(17): 1659-1667. DOI: 10.1016/j.jacc.2012.05.054
21
Halliday BP, Gulati A, Ali A, et al. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation, 2017, 135(22): 2106-2115. DOI: 10.1161/CIRCULATIONAHA.116.026910
22
Li R, Cui C, Lan T, et al. Late gadolinium enhancement distribution pattern of left ventricular wall in patients with dilated cardiomyopathy: a preliminary study. Zhonghua Xin Xue Guan Bing Za Zhi, 2020, 48(11): 922-929. DOI: , DOI: 10.3760/cma.j.cn112148-20200813-00638
23
Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson, 2013, 15(1): 922-929. DOI: 10.1186/1532-429X-15-92
24
aus dem Siepen F, Buss SJ, Messroghli D, et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging, 2015, 16(2): 210-216. DOI: 10.1093/ehjci/jeu183
25
Nakamori S, Dohi K, Ishida M, et al. Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging, 2018, 11(1): 48-59. DOI: 10.1016/j.jcmg.2017.04.006
26
Puntmann VO, Carr-White G, Jabbour A, et al. International T1 multicentre CMR outcome study. T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging, 2016, 9(1): 40-50. DOI: 10.1016/j.jcmg.2015.12.001
27
Youn JC, Hong YJ, Lee HJ, et al. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol, 2017, 27(9): 3924-3933. DOI: 10.1007/s00330-017-4817-9
28
Vita T, Gräni C, Abbasi SA, et al. Comparing CMR mapping methods and myocardial patterns toward heart failure outcomes in nonischemic dilated cardiomyopathy. JACC Cardiovasc Imaging, 2019, 12(8Pt 2): 1659-1669. DOI: 10.1016/j.jcmg.2018.08.021
29
Schuster A, Hor KN, Kowallick JT, et al. Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging, 2016, 9(4): e004077. DOI: 10.1161/CIRCIMAGING.115.004077
30
Buss SJ, Breuninger K, Lehrke S, et al. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging, 2015, 16(3): 307-315. DOI: 10.1093/ehjci/jeu181
31
Romano S, Judd RM, Kim RJ, et al. Feature-tracking global longitudinal strain predicts death in a multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy incremental to ejection fraction and late gadolini um enhancement. JACC Cardiovasc Imaging, 2018, 11(10): 1419-1429. DOI: 10.1016/j.jcmg.2017.10.024
32
Romano S, Judd RM, Kim RJ, et al. Association of feature-tracking cardiac magnetic resonance imaging left ventricular global longitudinal strain with all-cause mortality in patients with reduced left ventricular ejection fraction. Circulation, 2017, 135(23): 2313-2315. DOI: 10.1161/CIRCULATIONAHA.117.027740
33
Liu T, Gao Y, Wang H, et al. Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy. Heart, 2020: DOI: . DOI: 10.1136/heartjnl-2020-317949
34
Goh VJ, Le TT, Bryant J, et al. Novel Index of Maladaptive Myocardial Remodeling in Hypertension. Circ Cardiovasc Imaging, 2017, 10(9): e006840. DOI: 10.1161/CIRCIMAGING.117.006840
35
Xu Y, Lin J, Liang Y, et al. Prognostic value of left ventricular remodelling index in idiopathic dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging, 2020: DOI: . DOI: 10.1093/ehjci/jeaa144

PREV Research advances of magnetic resonance angiography in evaluating carotid arterystenosis
NEXT Application of cardiac magnetic resonance extracellular volume in hypertensive heart disease
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn